SCHEMBL2184149

SCHEMBL2184149

Cc1cccc(CC2CC(C(=O)O)N(C(=O)OC(C)(C)C)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.44
CYP1A2 P05177 1/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
NR1H2 P55055 3/20 0.43
NR1H3 Q13133 3/20 0.43
GPR119 Q8TDV5 1/20 0.40
AGTR2 P50052 2/20 0.39
TGM2 P21980 1/20 0.39
GRM2 Q14416 1/20 0.39
GRM3 Q14832 1/20 0.39
MCL1 Q07820 3/20 0.39
GRM5 P41594 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1371753 1.00 DPP4 (0.44) DPP4CYP1A2POLBCYP3A4CYP2C19
SCHEMBL6183345 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL6183348 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL21409001 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL1373084 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL9542940 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL13687997 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL7285245 0.89 NR1H2 (0.48) NR1H2NR1H3AGTR2MCL1
SCHEMBL24645661 0.88 NR1H2 (0.43) CYP1A2POLBCYP3A4CYP2C19NR1H2
SCHEMBL21409205 0.88 NR1H2 (0.43) CYP1A2POLBCYP3A4CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed